Pilot Study of Dexmedetomidine Sublingual Film for the Ambulatory Treatment of Hyperadrenergic Autonomic Crisis in Patients With Familial Dysautonomia

PHASE2Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

December 31, 2028

Conditions

Familial Dysautonomia

Interventions

DRUG

Dexmedetomidine Sublingual

Dexmedetomidine 120 mcg on two thin dissolvable films for sublingual administration

Trial Locations (1)

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER